In order to better understand, at a sub-molecular level, the minimal struct
ural requirements for the recognition process in the platelet aggregation i
nhibitory activity, a series of RGD mimetics were examined as fibrinogen re
ceptor antagonists variants. We simulate the electronic interactions betwee
n RGD with its biological receptor in terms of smaller molecules. MeCOO- wa
s used to mimic the side chain of deprotonated Asp and Meguanidinium group
mimicked the side chain of the protonated Arg. Alternative moieties present
on the RGD mimetics were also studied in this report. AM1: RHF/3-21G; B3LY
P/6-31+ +G** in the gas phase. Also, B3LYP/6-31+ +G** calculations using th
e IPCM solvation model were carried out for all the complexes. Our results
indicate that high level of theory calculations and the inclusion of solven
t effects are crucial in order to obtain satisfactory of accuracy in the el
ectronic distributions of these compounds. (C) 2001 Elsevier Science B.V. A
ll rights reserved.